These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39003446)

  • 1. LncRNA PITPNA-AS1 mediates the diagnostic potential of miR-129-5p in prostate cancer.
    Song Z; Xu S; Gu X; Feng Q; Wang C
    BMC Urol; 2024 Jul; 24(1):146. PubMed ID: 39003446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA PITPNA-AS1 regulates UNC5B expression in papillary thyroid cancer via sponging miR-129-5p.
    Mei S; Zong H; Zhou H
    Int J Biol Markers; 2021 Mar; 36(1):10-19. PubMed ID: 33706585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis.
    Guo Q; Li L; Bo Q; Chen L; Sun L; Shi H
    Biomed Pharmacother; 2020 Aug; 128():110072. PubMed ID: 32460193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression.
    Sun J; Zhang Y; Li B; Dong Y; Sun C; Zhang F; Jin L; Chen D; Wang W
    Cell Death Dis; 2019 Nov; 10(11):844. PubMed ID: 31700026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.
    Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y
    J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA PITPNA-AS1 promotes gastric cancer by increasing SOX4 expression via inhibition of miR-92a-3p.
    Liu L; Dai A; Zhang Z; Ning M; Han D; Li L; Li Z
    Aging (Albany NY); 2021 Sep; 13(17):21191-21201. PubMed ID: 34496348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA PITPNA-AS1 promotes cell proliferation and metastasis in hepatocellular carcinoma by upregulating PDGFD.
    Yao J; Liu X
    Aging (Albany NY); 2023 Mar; 15(10):4071-4083. PubMed ID: 37253627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-Coding RNA
    Yuan C; Yang L
    Cancer Manag Res; 2020; 12():12497-12507. PubMed ID: 33312000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
    Peng BH; Ji YF; Qiu XJ
    J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
    Ma X; Ren H; Zhang Y; Wang B; Ma H
    Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis.
    Wang QF; Wang QL; Cao MB
    Front Med (Lausanne); 2021; 8():668787. PubMed ID: 34055841
    [No Abstract]   [Full Text] [Related]  

  • 14. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PITPNA-AS1 Inhibits Cell Proliferation and Migration in Ovarian Cancer by Regulating the MIR-223-3p/RHOB Axis.
    Zhang F; Zhang M; Chen Z; Yu B; He X; Luo Y; Ai F; Hu W
    Rev Invest Clin; 2024 May; 76(2):103-115. PubMed ID: 38753591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of lncRNA EPB41L4A-AS1 promotes gastric cancer cell proliferation, migration and invasion.
    Ma J; Feng Y; Xu J; Li Z; Lai J; Guan H
    BMC Gastroenterol; 2024 Apr; 24(1):136. PubMed ID: 38627627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA BRE-AS1 interacts with miR-145-5p to regulate cancer cell proliferation and apoptosis in prostate carcinoma and has early diagnostic values.
    Chen Z; Zhen M; Zhou J
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actin filament-associated protein 1-antisense RNA1 promotes the development and invasion of tongue squamous cell carcinoma via the AFAP1-AS1/miR-133a-5p/ZIC2 axis.
    Tang M; Wu H; Zhang H; Xu X; Jiang B; Chen Q; Wei Y; Qian H; Han L
    J Gene Med; 2024 Jan; 26(1):e3654. PubMed ID: 38282153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.